bioRxivImmunology
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection
Z. Wang, P. Zhou, F. Muecksch, A. Cho, T. B. Tanfous, M. Canis, L. Witte, B. Johnson, R. Raspe, F. Schmidt, E. Bednarski, J. DaSilva, V. Ramos, S. Zong, M. Turroja, K. G. Millard, K. Yao, I. Shimeliovich, J. Dizon, A. Kaczynska, M. Jankovic, A. Gazumyan, T. Y. Oliveira, M. Caskey, C. Gaebler, , M. C. Nussenzweig
Abstract
Individuals that receive a 3rd mRNA vaccine dose show enhanced protection against severe COVID19 but little is known about the impact of breakthrough infections on memory responses. Here, we examine the memory antibodies that develop after a 3rd or 4th antigenic exposure by Delta or Omicron BA.1 infection, respectively. A 3rd exposure to antigen by Delta breakthrough increases the number of memory B cells that produce antibodies with comparable potency and breadth to a 3rd mRNA vaccine dose. A 4th antigenic exposure with Omicron BA.1 infection increased variant specific plasma antibody and memory B cell responses. However, the 4th exposure did not increase the overall frequency of memory B cells or their general potency or breadth compared to a 3rd mRNA vaccine dose. In conclusion, a 3rd antigenic exposure by Delta infection elicits strain-specific memory responses and increases in the overall potency and breadth of the memory B cells. In contrast, the effects of a 4th antigenic exposure with Omicron BA.1 is limited to increased strain specific memory with little effect on the potency or breadth of memory B cell antibodies. The results suggest that the effect of strain-specific boosting on memory B cell compartment may be limited.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
R. R. Goel, M. M. Painter, … E. J. Wherry·bioRxiv·Feb 20, 2022
- Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose
F. Muecksch, Z. Wang, … M. Nussenzweig·bioRxiv·Feb 14, 2022
- Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after mRNA but not adenovirus priming
G. E. Hartley, H. A. Fryer, … M. C. van Zelm·bioRxiv·Sep 15, 2023
- Recall of pre-existing cross-reactive B cell memory following Omicron breakthrough infection
C. I. Kaku, A. J. Bergeron, … L. M. Walker·bioRxiv·Apr 1, 2022
- Omicron BA.1 breakthrough infection drives long-term remodeling of the memory B cell repertoire in vaccinated individuals.
A. Sokal, G. Barba-Spaeth, … P. Chappert·bioRxiv·Jan 27, 2023
- Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variant.
S. Mise-Omata, M. Ikeda, … A. Yoshimura·bioRxiv·Jul 31, 2022